These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9885378)

  • 1. Increased serum concentration of circulating soluble receptor for interleukin-2 and its effect as a prognostic indicator in cachectic patients with gastric and colorectal cancer.
    Shibata M; Takekawa M
    Oncology; 1999; 56(1):54-8. PubMed ID: 9885378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer.
    Shibata M; Takekawa M; Amano S
    Surg Today; 1998; 28(9):884-8. PubMed ID: 9744395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
    Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N
    Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.
    Nakata B; Chung KH; Kato Y; Yamashita Y; Inui A; Arimoto Y; Maeda K; Onoda N; Sawada T; Sowa M
    Br J Cancer; 1998 Jun; 77(11):1820-4. PubMed ID: 9667652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.
    Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
    Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
    Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
    J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
    J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Soluble Interleukin-2 Receptor is Increased in Malnourished and Immunosuppressed Patients With Gastric and Colorectal Cancer: Possible Influence of Myeloid-Derived Suppressor Cells.
    Gonda K; Shibata M; Shimura T; Machida T; Suzuki S; Nakamura I; Ohki S; Sakurai K; Ohto H; Tomita R; Takenoshita S
    World J Oncol; 2012 Aug; 3(4):158-164. PubMed ID: 29147299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating ghrelin in patients with gastric or colorectal cancer.
    Huang Q; Fan YZ; Ge BJ; Zhu Q; Tu ZY
    Dig Dis Sci; 2007 Mar; 52(3):803-9. PubMed ID: 17245626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].
    Siemińska A
    Pol Merkur Lekarski; 2004 Feb; 16(92):188-90. PubMed ID: 15176308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.
    Naumnik W; Chyczewska E
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():185-6. PubMed ID: 11820599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
    Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma: in combination with the International Prognostic Index.
    Goto H; Tsurumi H; Takemura M; Ino-Shimomura Y; Kasahara S; Sawada M; Yamada T; Hara T; Fukuno K; Goto N; Okuno M; Takami T; Seishima M; Moriwaki H
    J Cancer Res Clin Oncol; 2005 Feb; 131(2):73-9. PubMed ID: 15503137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer.
    Sakata H; Murakami S; Hirayama R
    Int J Clin Oncol; 2002 Oct; 7(5):312-7. PubMed ID: 12402066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neopterin serum levels in pancreatic adenocarcinoma.
    Manes G; Spada OA; Rabitti PG; Feola B; Misso S; Minerva A; Uomo G
    Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
    Parasole R; Izzo F; Perrone F; Pignata S; Galati MG; Leonardi E; Castiglione F; Orlando R; Castello G; Esposito G; Gallo C; Daniele B
    Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.
    Gebauer G; Rieger M; Jäger W; Lang N
    Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.
    Goto N; Tsurumi H; Goto H; Shimomura YI; Kasahara S; Hara T; Yasuda I; Shimizu M; Murakami N; Yoshikawa T; Fukuno K; Takahashi T; Kito Y; Takami T; Moriwaki H
    Ann Hematol; 2012 May; 91(5):705-714. PubMed ID: 22183251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.